New York State Common Retirement Fund Crinetics Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 137,918 shares of CRNX stock, worth $4.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
137,918
Previous 155,426
11.26%
Holding current value
$4.64 Million
Previous $7.95 Million
41.79%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding CRNX
# of Institutions
246Shares Held
82.1MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$210 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$207 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$182 Million0.03% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.29MShares$144 Million10.24% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.81B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...